They joined us !
Creation: september 2000
Employees: 180
Address: Centre Hospitalier Lyon-Sud (Pierre-Bénite, France), CHU Saint-Louis (Paris, France), CHU Henri Mondor (Créteil, France)
Activity (biotech/medtech/healthtech) : biotech
Who ?
LYSARC, based in Lyon, is the largest academic organization in Europe dedicated to clinical research on lymphoma and CLL/WM. It leads clinical studies (phases 1 to 4), non-interventional research, and data reuse projects. With expert platforms in pathology, biology, and imaging, and accredited by the French National Cancer Institute (INCa), LYSARC conducts innovative projects on an international scale.
Why ?
“As the largest academic organization in Europe dedicated to clinical research on lymphoma and CLL/WM, LYSARC leads large-scale international projects thanks to its specialized platforms and recognized expertise, from early development to data reuse. Becoming a member of Lyonbiopôle represents a strategic opportunity for us to strengthen our presence within a leading health innovation ecosystem in the Auvergne-Rhône-Alpes region, to foster public-private synergies, and to accelerate the availability of innovative therapeutic solutions for patients with lymphoma or CLL/WM.”
Florence AGOSTINO-ETCHETTO, CEO